Advisor Toxicologist (MIH Leadership Development Program) - ELI Lily & Company

Advisor Toxicologist (MIH Leadership Development Program) - ELI Lily & Company

Apr 16, 2024

Chiamaka (Chi-Chi) Ukachukwu, Ph.D is an ‘Advisor’ and she is a full-time employee in the Medicines Innovation Hub (MIH) Leadership Development Program (LDP).

Director, Alliances - Arrowhead Pharmaceuticals

Director, Alliances - Arrowhead Pharmaceuticals

Apr 09, 2024

Tamisha Vaughan, PhD, manages programs Arrowhead has partnered with or licensed ranging from Discovery to Ph3 stages.

Advisor in Investigative Toxicology at Eli Lily

Advisor in Investigative Toxicology at Eli Lily

Apr 02, 2024

Ariana D. Cherry PhD, is a part of Talent Development Academy (TDA) Leadership Development Rotational Program (LDP). She was hired on as a full-time employee with the opportunity to complete three, 8-

Preclinical Senior Scientist in Oral Formulations at Merck

Preclinical Senior Scientist in Oral Formulations at Merck

Mar 26, 2024

Mario Guitierrez, PhD, is a Preclinical Senior Scientist in Oral Formulations at Merck. As a formulation scientist, he works to optimize drug product formulations for clinical supply.

Preclinical Toxicologist at Johnson & Johnson Innovative Medicine

Preclinical Toxicologist at Johnson & Johnson Innovative Medicine

Mar 19, 2024

Kelsey Johnson, PhD, is a Preclinical Toxicologist. She coordinates toxicology studies focused on assessing potential adverse effects of novel pharmaceutical compounds.

Sr. Scientist of Regulatory Affairs International at Merck & Co.

Sr. Scientist of Regulatory Affairs International at Merck & Co.

Mar 12, 2024

LaKeisha Batts PhD, provides regulatory oversight for the development and approval of clinical trial applications (Phases I-V) in ex-US countries and have global responsibility for all regulatory acti

System Verification Engineer at Johnson & Johnson

System Verification Engineer at Johnson & Johnson

Mar 05, 2024

System Verification Engineer: create, validate, and execute test methods to verify capital system requirements.

Senior Scientist at AstraZeneca

Senior Scientist at AstraZeneca

Feb 27, 2024

I work as a senior scientist for AstraZeneca were I am part of a team that evaluates oncology drug
targets and novel therapies.

Associate Director, DPDS Programs & Business Operations at J & J Innovative Med

Associate Director, DPDS Programs & Business Operations at J & J Innovative Med

Feb 20, 2024

She leads early career development programs and strategic operations for their discovery organization to ensure that their business is running efficiently

Physician-Scientist at Johnson & Johnson

Physician-Scientist at Johnson & Johnson

Feb 14, 2024

I practice evidence-based medicine by integrating pharmacology, exposure, epidemiology, and clinical data to drive drug development decisions with a patient-centric focus.

Associate Director in Upstream Development, J&J Innovative Medicines

Associate Director in Upstream Development, J&J Innovative Medicines

Dec 13, 2023

Dr. Nancy Guillen was recently appointed as an Associate Director in Upstream Development at (J&J) Innovative Medicines

Senior New Product Development Engineer, Edwards Lifesciences

Senior New Product Development Engineer, Edwards Lifesciences

Dec 11, 2023

David Swain works in works in the Advanced Technology Business unit at Edwards Lifesciences

Medical Sciences Liaison (MSL), Merck

Medical Sciences Liaison (MSL), Merck

Dec 11, 2023

Dr. Alia Toro is a Medical Sciences Liaison (MSL) who provides support to the Oncology Department at Merck, Puerto Rico.

Investigator in R&D drug discovery, GSK

Investigator in R&D drug discovery, GSK

Dec 05, 2023

Dr. Ivelisse Cruz-Torres works in matrix teams with the goal of evaluating potential targets to treat neurodegenerative diseases.

Scientist, Sr. Managing Leader, Lily

Scientist, Sr. Managing Leader, Lily

Nov 28, 2023

Dr. Hugo Caicedo is a Sr. Director in the Accelerated R&D Leadership Program at Eli Lilly and Company.